Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (131-140 of 225) with videos related to

Pageof 23
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 22, 2008
[Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis]M Sailer, F Fazekas, A Gass, et al.
Brain : a Journal of Neurology|August 28, 2001
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosisR L Lindberg, C J De Groot, L Montagne, et al.
Journal of Neurology|March 4, 2000
The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurementP D Molyneux, D H Miller, M Filippi, et al.
Thrombosis and Haemostasis|May 3, 1993
Lack of association between antiphospholipid antibodies and migraineD A Tsakiris, L Kappos, G Reber, et al.
European Journal of Neurology|March 23, 2017
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studiesE Havrdova, G Giovannoni, R Gold, et al.
Neurology|January 26, 2005
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1aM Hardmeier, S Wagenpfeil, P Freitag, et al.
Brain : a Journal of Neurology|January 5, 1999
Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosisD Leppert, J Ford, G Stabler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosisF Gilli, F Hoffmann, A Sala, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2010
Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patientsR A Rudick, L Kappos, R Kinkel, et al.
European Journal of Neurology|January 6, 2015
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosisL Kappos, G Giovannoni, R Gold, et al.
Pageof 23

Showing results (131-140 of 225) with videos related to

Sort By:
Pageof 23
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 22, 2008
[Cerebral and spinal MRI examination in patients with clinically isolated syndrome and definite multiple sclerosis]M Sailer, F Fazekas, A Gass, et al.
Brain : a Journal of Neurology|August 28, 2001
The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosisR L Lindberg, C J De Groot, L Montagne, et al.
Journal of Neurology|March 4, 2000
The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurementP D Molyneux, D H Miller, M Filippi, et al.
Thrombosis and Haemostasis|May 3, 1993
Lack of association between antiphospholipid antibodies and migraineD A Tsakiris, L Kappos, G Reber, et al.
European Journal of Neurology|March 23, 2017
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studiesE Havrdova, G Giovannoni, R Gold, et al.
Neurology|January 26, 2005
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1aM Hardmeier, S Wagenpfeil, P Freitag, et al.
Brain : a Journal of Neurology|January 5, 1999
Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosisD Leppert, J Ford, G Stabler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Qualitative and quantitative analysis of antibody response against IFNbeta in patients with multiple sclerosisF Gilli, F Hoffmann, A Sala, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 23, 2010
Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patientsR A Rudick, L Kappos, R Kinkel, et al.
European Journal of Neurology|January 6, 2015
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosisL Kappos, G Giovannoni, R Gold, et al.
Pageof 23